Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Mirada Medical Limited announced that it will be launching Casemeeting, a new product designed to improve image presentation at tumor board meetings, at the RSNA-2010 .

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced that it will be launching Casemeeting, a new product designed to improve image presentation at tumor board meetings, at the RSNA-2010 ( Radiological Society of North America ) trade show in Chicago, Illinois from November 28 - December 3, 2010.

The Tumor Board meeting has become a key instrument for sites seeking to personalise best practise to individual patients. Mirada Casemeeting will significantly reduce the burden of Tumor Board preparation for radiologists without compromising on the quality of the information presented. Using Casemeeting, radiologists will be able to send key images, findings and full volumetric data directly from the reading workstation to Tumor Board. The system will then automatically generate a presentation for each patient.

During Tumor Board, Casemeeting users will be able to simply select the patient and present all of the key information without the need for additional preparation time, data transfer or setup. Importantly, at any time during the meeting, the presenter is only a single click away from a synchronised, fully featured 3D view of all the case images, including tools for multi-planar reconstructed views, fusion for PET/CT and MR- PET , multi-timepoint for response assessment and quantification tools.  In addition, text, image or attachment slides can also be added by other meeting attendees including medical oncologists, pathologists, radiation oncologists, surgeon and the meeting Chair.

Casemeeting is the third offering in Mirada's suite of oncology imaging products which together support the sharing and communication of advanced diagnostic findings and quantifications amongst all clinicians responsible for a patient's management.  The Casemeeting software is complementary to XD3, Mirada's advanced diagnostic imaging review software, and Caseaccess which give the referrer web-based access of data and findings available.

Casemeeting will be launched globally by Mirada Medical in early 2011 and the programme will be available for demonstration in Mirada Medical's booth at the RSNA Annual Meeting.  Mirada Medical will showcase all of its latest industry leading developments in Booth 7520, Hall B, North Building of McCormick Place.

Mirada's technologies are developed by world renowned scientists and dedicated engineers and the Company is focused on providing users with oncology imaging solutions to enhance their workflow whilst optimising the most accurate and consistent reporting and quantitative knowledge share in the multi-modal diagnosis and treatment of cancer.

Hugh Bettesworth, Chief Executive of Mirada Medical, said: "A pre-requisite to personalised medicine is effective inter-disciplinary communication and discussion of pertinent clinical information for the specific case under review. Our aim is to allow the highest quality of diagnostic imaging information to be available to all of the specialists who typically work together with the patient to treat cancer cases. The introduction of Casemeeting now means that a complete set of images and findings can be quickly prepared for the tumor board meeting, and presented with the ability to review the case in advanced visualization software should the need arise."

Source: Mirada Medical